Horizon Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Horizon Investments’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-26,178	Closed	-$320K	–	121
2015 Q3	$320K	Hold	26,178	–	–	0.03%	68
2015 Q2	$247K	Hold	26,178	–	–	0.02%	71
2015 Q1	$232K	Hold	26,178	–	–	0.02%	79
2014 Q4	$263K	Hold	26,178	–	–	0.03%	72
2014 Q3	$176K	Buy	+26,178	New	+$184K	0.02%	104

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Horizon Investments's BEAT Position: Q4 2015 in Review

Horizon Investments sold out of BioTelemetry, Inc. (BEAT) in Q4 2015, closing a stake of 26,178 shares — an estimated $320K sold.

Horizon Investments first reported a position in BEAT in Q3 2014 and held it in 5 quarters. The position peaked at $320K in Q3 2015. 115 funds tracked by Wall St. Rank hold BEAT as of Q4 2015.

Horizon Investments reported no remaining BioTelemetry, Inc. position as of Q4 2015 after selling out during the quarter.
Horizon Investments sold 26,178 BioTelemetry, Inc. shares in Q4 2015, an estimated $320K.
Horizon Investments first reported a position in BioTelemetry, Inc. in Q3 2014 and held it in 5 quarters.
Horizon Investments's BioTelemetry, Inc. position peaked at $320K in Q3 2015.
115 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2015.

Based on Horizon Investments's 13F filing for Q4 2015, filed 10 Feb 2016.